Some essential considerations in the design and conduct of non-inferiority trials

Clinical Trials: Discerning Hype From Substance

(2013) Thomas R. Fleming   ANNALS OF INTERNAL MEDICINE

Addressing Missing Data in Clinical Trials

(2013) Thomas R. Fleming   ANNALS OF INTERNAL MEDICINE

PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomized, Active-Controlled Trial

(2010) Patrick Peterson et al.   Statistics in Biopharmaceutical Research

Comment on “PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomised, Active-Controlled Trial”

(2010) David Brown   Statistics in Biopharmaceutical Research

Issues in Noninferiority Trials: The Evidence in Community‐Acquired Pneumonia

(2008) Thomas R. Fleming et al.   CLINICAL INFECTIOUS DISEASES

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Noninferiority and equivalence trials: deciphering ‘similarity’ of medical interventions

(2008) John H. Powers   STATISTICS IN MEDICINE

Current issues in non-inferiority trials

(2007) Thomas R. Fleming   STATISTICS IN MEDICINE

Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials

(2007) Steven Snapinn et al.   STATISTICS IN MEDICINE